Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Berry Lance A	2. Issuer Name and Ticker or Trading Symbol Wright Medical Group N.V. [ WMGI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Chief Finan./Op. Officer
(Last) (First) (Middle) 1023 CHERRY ROAD	3. Date of Earliest Transaction (MM/DD/YYYY) 11/19/2019
(Street) MEMPHIS, TN 38117 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares, par value EUR 0.03 per share	11/19/2019		M⁽¹⁾		9635	A	$17.82	143143 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/19/2019		M⁽¹⁾		12528	A	$15.04	155671 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/19/2019		M⁽¹⁾		1924	A	$17.7	157595 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/19/2019		M⁽¹⁾		19557	A	$20.75	177152 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/19/2019		M⁽¹⁾		30602	A	$23.93	207754 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/19/2019		M⁽¹⁾		88654	A	$20.62	296408 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/19/2019		S⁽¹⁾		162900	D	$29.5617 ⁽³⁾	133508 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/20/2019		M⁽¹⁾		28845	A	$20.62	162353 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/20/2019		M⁽¹⁾		50605	A	$21.24	212958 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/20/2019		M⁽¹⁾		18122	A	$27.86	231080 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/20/2019		M⁽¹⁾		11364	A	$24.49	242444 ⁽²⁾	D
Ordinary Shares, par value EUR 0.03 per share	11/20/2019		S⁽¹⁾		108936	D	$29.5025 ⁽⁴⁾	133508 ⁽²⁾	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$17.82	11/19/2019		M ⁽¹⁾			9635	⁽⁵⁾	5/13/2020	Ordinary Shares	9635	$0	0	D
Stock Option (right to buy)	$15.04	11/19/2019		M ⁽¹⁾			12528	⁽⁵⁾	5/11/2021	Ordinary Shares	12528	$0	0	D
Stock Option (right to buy)	$17.7	11/19/2019		M ⁽¹⁾			1924	⁽⁵⁾	4/16/2022	Ordinary Shares	1924	$0	0	D
Stock Option (right to buy)	$20.75	11/19/2019		M ⁽¹⁾			19557	⁽⁵⁾	5/9/2022	Ordinary Shares	19557	$0	0	D
Stock Option (right to buy)	$23.93	11/19/2019		M ⁽¹⁾			30602	⁽⁵⁾	5/14/2023	Ordinary Shares	30602	$0	0	D
Stock Option (right to buy)	$20.62	11/19/2019		M ⁽¹⁾			88654	⁽⁵⁾	10/13/2025	Ordinary Shares	88654	$0	28845	D
Stock Option (right to buy)	$20.62	11/20/2019		M ⁽¹⁾			28845	⁽⁵⁾	10/13/2025	Ordinary Shares	28845	$0	0	D
Stock Option (right to buy)	$21.24	11/20/2019		M ⁽¹⁾			50605	⁽⁶⁾	7/19/2026	Ordinary Shares	50605	$0	10190	D
Stock Option (right to buy)	$27.86	11/20/2019		M ⁽¹⁾			18122	⁽⁷⁾	7/25/2027	Ordinary Shares	18122	$0	14125	D
Stock Option (right to buy)	$24.49	11/20/2019		M ⁽¹⁾			11364	⁽⁸⁾	7/24/2028	Ordinary Shares	11364	$0	25013	D

Explanation of Responses:
(1)	Exercise and sale of vested stock options in connection with 280G tax planning.
(2)	Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
(3)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.53 to $29.605, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
(4)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.47 to $29.54, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
(5)	This option has fully vested.
(6)	This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
(7)	This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
(8)	This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Berry Lance A 1023 CHERRY ROAD MEMPHIS, TN 38117			EVP, Chief Finan./Op. Officer